TEVA UK LIMITED

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2025	3	Value not published	3

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierTEVA UK LIMITED

At-a-glance view of the first 2 buyers in the ranked list below.

NHS England4 awards · no published value assigned · 4 values excluded
Business Services Organisation Procurement and Logistics Service1 award · no published value assigned · 1 values excluded

Source records

Published awards

5 records linked to this supplier.

NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products
Buyer: NHS England
End date in notice
30 Sept 2027Date from the linked contract
Value shown in notice
£21,562,716Value from the linked contract
Official source
Open the official Find a Tender notice for NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-058823 / 2
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Buyer: NHS England

TEVA UK LIMITED

Published records by year

Buyer relationships by value counted

Published awards

NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

NHS National Framework for Transition products (Axitinib and Eltrombopag)

Lot 1 - CM/TNS/25/5725/01

Generic, Branded Generic & Proprietary Medicinal Products - Group 18